Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Short term Debt (2017 - 2025)

Selectis Health's Short term Debt history spans 12 years, with the latest figure at $11.8 million for Q3 2025.

  • For Q3 2025, Short term Debt fell 7.81% year-over-year to $11.8 million; the TTM value through Sep 2025 reached $11.8 million, down 7.81%, while the annual FY2024 figure was $11.5 million, 2.51% up from the prior year.
  • Short term Debt for Q3 2025 was $11.8 million at Selectis Health, up from $11.3 million in the prior quarter.
  • Across five years, Short term Debt topped out at $12.8 million in Q3 2024 and bottomed at $150000.0 in Q2 2022.
  • The 5-year median for Short term Debt is $10.6 million (2024), against an average of $8.2 million.
  • The largest annual shift saw Short term Debt plummeted 97.92% in 2022 before it surged 7089.05% in 2023.
  • A 5-year view of Short term Debt shows it stood at $6.3 million in 2021, then tumbled by 63.61% to $2.3 million in 2022, then surged by 386.33% to $11.2 million in 2023, then increased by 2.51% to $11.5 million in 2024, then rose by 2.75% to $11.8 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Short term Debt are $11.8 million (Q3 2025), $11.3 million (Q2 2025), and $11.4 million (Q1 2025).